​ReIMAGINE Prostate Cancer Risk Study:
Replacing biopsies with precision diagnosis
 

The team aims to recruit 1,000 men with medium to high risk cancers to find out if MRI can be combined with other high-tech diagnostic tests to predict cancer progression. The ultimate aim is to develop tests that are better than biopsies for targeting the right cancer treatment to the right person (including determining if they don’t need treatment).

 

Risk recruitment sites:

• University College London Hospitals NHS Foundation Trust 

• Imperial College Healthcare NHS Trust

• Royal Free London NHS Foundation Trust

 

This study is now closed to recruitment

 

More information can be found here: ReIMAGINE Prostate Cancer Risk - Full Text View - ClinicalTrials.gov

​

​

​